Reizer joins AristaMD as chief product officer, where he will leverage his deep expertise in developing novel provider-centric solutions. He will lead AristaMD’s product strategy to deliver on the company’s mission to expedite time to treatment, decrease costs and drive better patient outcomes.
AristaMD has been first to market with numerous solutions that revolutionize the delivery of care. In the last two years, the company has launched new additions to their core eConsult platform that include longitudinal diabetic education, a proprietary imaging app, custom specialist panels and COVID-19 eConsults. AristaMD also continues to be the only eConsult platform on the Epic App Orchard marketplace.
“Neal is a successful, provider-centric leader who has expertise with digital health solutions used in every health care environment, from inpatient to home health to ambulatory care settings,” said Brooke LeVasseur, CEO of AristaMD. “He maintains deep knowledge of clinical workflows and holds a track-record of delivering products with sustainable value to patients and providers.”
“I’ve been impressed with AristaMD’s unwavering commitment to addressing the country’s pressing need to improve access to care,” said Reizer. “I look forward to partnering with Brooke and the outstanding team she has assembled to further drive the engagement, development and adoption of their industry-leading telehealth collaboration solutions.
To learn more about AristaMD, please visit www.aristamd.com.
About AristaMD
AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult platform provides a telehealth solution that empowers primary care providers to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. Designed to seamlessly integrate into physician referral workflows, the platform allows payers and providers to quickly and cost-effectively launch specialist eConsults using their own specialists or those provided by AristaMD’s board-certified panel of experts. AristaMD’s platform has proven to deliver cost-effective, timely access to specialty care through eConsults, significantly reducing the need for face-to-face visits while increasing patient satisfaction. AristaMD partners with healthcare stakeholders to ensure their success in the transition to value-based care. For additional information, visit www.aristamd.com, or follow AristaMD on LinkedIn and Twitter.